FDA Oncologic Drugs Advisory Committee Is Holding A Meeting Today From 12:30-5:00PM ET To Discuss Karyopharm's New Drug Application Requesting Accelerated Approval For Selinexor, A First-In-Class, Oral Selective Inhibitor Of Nuclear Export Comp
Benzinga_Newsdesk